Vitiligo: Recent insights and new therapeutic approaches

T. M. Lotti, S. F. Berti, J. Hercogova, R. H. Huggins, B. W. Lee, C. K. Janniger, R. A. Schwartz

Research output: Contribution to journalReview articlepeer-review

9 Scopus citations


Vitiligo represents a selective destruction of the melanocytes. It is a relatively common, probably autoimmune disorder that affects people of all backgrounds and both genders. No particular group seems to be preferentially affected. Half of vitiligo patients have an onset before the age of 18 years. In regions where leprosy is endemic, individuals with vitiligo are often stigmatized due to similarities in appearance between the two diseases. We will review this important subject, emphasizing the latest therapeutic advances.

Original languageEnglish (US)
Pages (from-to)637-647
Number of pages11
JournalGiornale Italiano di Dermatologia e Venereologia
Issue number6
StatePublished - Dec 2012

All Science Journal Classification (ASJC) codes

  • Dermatology


  • Autoimmunity
  • Skin diseases
  • Vitiligo


Dive into the research topics of 'Vitiligo: Recent insights and new therapeutic approaches'. Together they form a unique fingerprint.

Cite this